Feasibility testing of a double-blind, randomized, placebo-controlled trial of individualized homoeopathic medicines in pediatric upper respiratory tract infection

D N De Homoeopathic Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Children of age group 1-11 years and of either sex
•2. Clinical signs and symptoms of an URTI with a duration of >= 24 hours with or without fever >=37.5áµ?C
•3. At least 1 of 3 types of URTI symptoms â?? nasal (plugged nose, runny nose, sneezing), pharyngeal (scratchy throat, sore throat, pharyngeal hyperaemia), and cough (ordinary cough without suspicion of acute lower respiratory tract disease)
•4. At least 1 of 5 general symptoms â?? feeling tired, weakness, body ache, irritable or whiney, or less active.
•5. Literate guardians or attendants capable of understanding and filling the questionnaire and providing written informed consent.

•1. Severe or complicated course of URTI
•2. Signs of acute LRTI
•3. COVID-19 positive cases as diagnosed by RT-PCR method
•4. Current symptoms mainly induced by other acute ENT diseases
•5. Daily use of antibiotics, steroids and cytotoxic agents
•6. Diagnosed cases of unstable developmental, mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure
•7. Immune-compromised state, and
•8. Already undergoing homoeopathic or other modes of treatment for URTI.

发起方

D N De Homoeopathic Medical College and Hospital